Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
HemContricolbiomedical.com · Low evidenceTricol Biomedical is a medical device company that develops hemostatic and wound care products using its proprietary chitosan technology, Chito+. Its HemCon product line, originally developed for battlefield trauma, now serves trauma management, procedural care, and consumer self-care markets.
Parse Score